Error loading player: No playable sources found

Viral Safety of Biotechnology Products – Changing the Regulatory Landscape, Modalities and Analytical Technologies - Japanese

Date
December 6, 2022
This product is not available for individual purchase, but it is available as part of the following products:


Related Products

Thumbnail for Closing Remarks - English
Closing Remarks - English
Julia Edwards, Genentech, a Member of the Roche Group
Thumbnail for Cell & Gene Therapy Products – Showcase both Regulatory and CMC Issues via Case Studies and Recent Challenges Toward Solving Regulatory Issues in Japan - English
Cell & Gene Therapy Products – Showcase both Regulatory and CMC Issues via Case Studies and Recent Challenges Toward Solving Regulatory Issues in Japan - English
Recently, as the number of approved Regenerative Medical Products (RMPs) in Japan has been rising, companies are expected to face a number of challenges specific to the Cell Therapy and/or Gene Therapy Products…